Table 1.
Training set isolate phenotypes.
| Drug | Resistant (n) | Susceptible (n) | Total (n) | Resistant proportion |
|---|---|---|---|---|
| Isoniazid | 4232 | 5723 | 9955 | 0.425 |
| Rifampicin | 3472 | 6428 | 9900 | 0.351 |
| Ethambutol | 2273 | 6390 | 8663 | 0.262 |
| Pyrazinamide | 1505 | 5393 | 6898 | 0.218 |
| Streptomycin | 2643 | 4362 | 7005 | 0.377 |
| Amikacin | 773 | 2632 | 3405 | 0.227 |
| Capreomycin | 737 | 2838 | 3575 | 0.206 |
| Kanamycin | 796 | 2502 | 3298 | 0.241 |
| Ciprofloxacin | 118 | 388 | 506 | 0.233 |
| Ofloxacin | 912 | 2246 | 3158 | 0.289 |
| Moxifloxacin | 398 | 1941 | 2339 | 0.170 |
| Levofloxacin | 66 | 189 | 255 | 0.259 |
| Ethionamide | 791 | 1647 | 2438 | 0.324 |
| Total isolates | 10,201 |
Phenotypic summary of the 10,201 isolates used to train and cross-validate the models: the numbers of resistant isolates, susceptible isolates, the total tested (sum of the numbers of resistant and susceptible isolates), and the resistant proportion, with respect to each of the 13 anti-TB drugs.